Quick Answer
ACADIA PHARMACEUTICALS INC reported Research And Development Expense of $328.80 million for the year ending 2025.
- ACADIA PHARMACEUTICALS INC showed an increase of +8.4% in Research And Development Expense from 2024 to 2025.
- This data is from ACADIA PHARMACEUTICALS INC's annual report (Form 10-K), filed with the SEC on February 26, 2026.
- XBRL data for this metric is available from 2009 to 2025 (17 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q2 2010: $5.04 million | Q3 2010: $4.97 million | Q1 2011: $4.41 million | Q2 2011: $4.32 million | Q3 2011: $4.16 million | Q1 2012: $5.02 million | Q2 2012: $4.47 million | Q3 2012: $4.40 million | Q1 2013: $4.43 million | Q2 2013: $7.11 million | Q3 2013: $7.25 million | Q1 2014: $11.67 million | Q2 2014: $13.80 million | Q3 2014: $16.95 million | Q1 2015: $16.30 million | Q2 2015: $18.38 million | Q3 2015: $18.73 million | Q1 2016: $22.78 million | Q2 2016: $20.48 million | Q3 2016: $25.81 million | Q1 2017: $35.41 million | Q2 2017: $34.18 million | Q3 2017: $36.42 million | Q1 2018: $39.28 million | Q2 2018: $46.59 million | Q3 2018: $53.11 million | Q1 2019: $52.92 million | Q2 2019: $67.32 million | Q3 2019: $62.62 million | Q1 2020: $72.64 million | Q2 2020: $64.30 million | Q3 2020: $120.08 million | Q1 2021: $56.97 million | Q2 2021: $56.94 million | Q3 2021: $58.57 million | Q1 2022: $128.86 million | Q2 2022: $75.65 million | Q3 2022: $81.34 million | Q1 2023: $69.14 million | Q2 2023: $58.77 million | Q3 2023: $156.96 million | Q1 2024: $59.68 million | Q2 2024: $76.23 million | Q3 2024: $66.61 million | Q1 2025: $78.27 million | Q2 2025: $77.95 million | Q3 2025: $87.83 million.
- Over the full 17 years of available data (2009 to 2025), ACADIA PHARMACEUTICALS INC's Research And Development Expense has grown by 690.7%.
- Historical annual values: Fiscal year 2025: $328.80 million | Fiscal year 2024: $303.25 million | Fiscal year 2023: $351.62 million | Fiscal year 2022: $361.58 million | Fiscal year 2021: $239.42 million | Fiscal year 2020: $319.13 million | Fiscal year 2019: $240.39 million | Fiscal year 2018: $187.16 million | Fiscal year 2017: $149.19 million | Fiscal year 2016: $99.28 million | Fiscal year 2015: $73.87 million | Fiscal year 2014: $60.60 million | Fiscal year 2013: $26.72 million | Fiscal year 2012: $18.79 million | Fiscal year 2011: $17.31 million | Fiscal year 2010: $20.58 million | Fiscal year 2009: $41.59 million.
- Data sourced from SEC EDGAR public filings as of August 5, 2026.
Last verified: